The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction

American Journal of Emergency Medicine

Volumn 34, Issue 8, 2016, Pages 1542-1547

  Balta, Sevket ^a   Celik, Turgay ^a   Ozturk, Cengiz ^a   Kaya, M Gungor ^b   Aparci, Mustafa ^a   Yildirim, A Osman ^a   Demir, Mustafa ^a   Kilic, Selim ^a   Aydin, İbrahim ^a   Iyisoy, Atila ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTE; NO-REFLOW PHENOMENON; PATHOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; ST ELEVATION MYOCARDIAL INFARCTION;

BIOMARKERS; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; NO-REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; ST ELEVATION MYOCARDIAL INFARCTION;

EID: 84970021371     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2016.05.031     Document Type: Article

References (29)

1. [1] Durante, A, Camici, PG, Novel insights into an “old” phenomenon: the no reflow. Int J Cardiol 187 (2015), 273–280.
2. [2] Celik, T, Kaya, MG, Akpek, M, Gunebakmaz, O, Balta, S, Sarli, B, et al. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction. Angiology 66:2 (2015), 155–162.
3. [3] Celik, T, Balta, S, Ozturk, C, Kaya, MG, Aparci, M, Yildirim, OA, et al. Predictors of no-reflow phenomenon in young patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology, 2015.
4. [4] Celık, T, Balta, S, Demır, M, Yıldırım, AO, Kaya, MG, Ozturk, C, et al. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiol J 23:1 (2016), 84–92.
5. [5] Schwartz, BG, Kloner, RA, Coronary no reflow. J Mol Cell Cardiol 52:4 (2012 Apr), 873–882.
6. [6] Young, JJ, Cox, DA, Stuckey, T, Babb, J, Turco, M, Lansky, AJ, et al. Prospective, multicenter study of thrombectomy in patients with acute myocardial infarction: the X-tract AMI registry. J Interv Cardiol 20:1 (2007 Feb), 44–50.
7. [7] Mehta, RH, Harjai, KJ, Boura, J, Cox, D, Stone, GW, O'Neill, W, et al. Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol 92:12 (2003), 1445–1447.
8. [8] Balta, S, Celik, T, Mikhailidis, DP, Ozturk, C, Demirkol, S, Aparci, M, et al. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost, 2015 [pii: 1076029615569568, Epub ahead of print].
9. [9] Hilgendorf, I, Swirski, FK, Robbins, CS, Monocyte fate in atherosclerosis. Arterioscler Thromb Vasc Biol 35:2 (2015), 272–279.
10. [10] Kanbay, M, Solak, Y, Unal, HU, Kurt, YG, Gok, M, Cetinkaya, H, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol 46:8 (2014), 1619–1625.
11. [11] Thygesen, K, Alpert, JS, Jaffe, AS, Simoons, ML, Chaitman, BR, White, HD, et al. Third universal definition of myocardial infarction. Circulation 126:16 (2012), 2020–2035.
12. [12] Colaco, R, Reay, P, Beckett, C, Aitchison, TC, Mcfarlane, PW, False positive ECG reports of anterior myocardial infarction in women. J Electrocardiol 33 (2000), 239–244 [Suppl.].
13. [13] The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI study group. N Engl J Med, 312(14), 1985, 932–936.
14. [14] Rezkalla, SH, Kloner, RA, No-reflow phenomenon. Circulation 105:5 (2002), 656–662.
15. [15] Rezkalla, SH, Dharmashankar, KC, Abdalrahman, IB, Kloner, RA, No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. J Interv Cardiol 23:5 (2010), 429–436.
16. [16] Ito, H, No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med 3:9 (2006), 499–506.
17. [17] Gibson, CM, de Lemos, JA, Murphy, SA, Marble, SJ, McCabe, CH, Cannon, CP, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 103:21 (2001), 2550–2554.
18. [18] Miranda-Guardiola, F, Rossi, A, Serra, A, Garcia, B, Rumoroso, JR, Iñiguez, A, et al. Angiographic quantification of thrombus in ST-elevation acute myocardial infarction presenting with an occluded infarct-related artery and its relationship with results of percutaneous intervention. J Interv Cardiol 22:3 (2009), 207–215.
19. [19] Sianos, G, Papafaklis, MI, Serruys, PW, Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol 22:10 Suppl. B (2010), 6B–14B.
20. [20] Balta, S, Cakar, M, Demirkol, S, Kurt, O, Unlu, M, Kucuk, U, The relationship between ankle-brachial index and estimated glomerular filtration rate in type 2 diabetes. Angiology, 64(3), 2013 Apr, 242.
21. [21] Lang, RM, Bierig, M, Devereux, RB, Flachskampf, FA, Foster, E, Pellikka, PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr 7:2 (2006 Mar), 79–108.
22. [22] Kurtul, A, Murat, SN, Yarlioglues, M, Duran, M, Celik, IE, Kilic, A, Mild to moderate renal impairment is associated with no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. Angiology, 2014.
23. [23] Ndrepepa, G, Tiroch, K, Fusaro, M, Keta, D, Seyfarth, M, Byrne, RA, et al. 5-Year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 55:21 (2010), 2383–2389.
24. [24] van de Woestijne, AP, van der Graaf, Y, Liem, A-H, Cramer, MJM, Westerink, J, Visseren, FLJ, et al. Low high-density lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication. J Am Coll Cardiol 62:20 (2013), 1834–1841.
25. [25] Canpolat, U, Çetin, EH, Cetin, S, Aydin, S, Akboga, MK, Yayla, C, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb Hemost, 2015.
26. [26] Canpolat, U, Aytemir, K, Yorgun, H, Şahiner, L, Kaya, EB, Çay, S, et al. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation. Europace 17:12 (2015), 1807–1815.
27. [27] Kundi, H, Kiziltunc, E, Cetin, M, Cicekcioglu, H, Cetin, ZG, Cicek, G, et al. Association of monocyte/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease. Herz, 2016.
28. [28] Cetin, EHO, Cetin, MS, Canpolat, U, Aydin, S, Topaloglu, S, Aras, D, et al. Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Biomark Med 9:10 (2015), 967–977.
29. [29] Çiçek, G, Kundi, H, Bozbay, M, Yayla, C, Uyarel, H, The relationship between admission monocyte HDL-C ratio with short-term and long-term mortality among STEMI patients treated with successful primary PCI. Coron Artery Dis, 2016.